Moderna, Inc. invites you to their event

Series: High Risk Populations - Most Recent COVID-19 Vaccination Recommendations

About this event

Please join us over the next several weeks for a series of live, virtual events to discuss the most recent ACIP recommendations and the continued risks and consequences of COVID-19 infections in high-risk populations.

We've assembled a panel of experts to discuss strategies for protecting groups who remain at high risk of severe COVID-19, including:

  • Older adults - Nov. 7th at 12pm ET
  • Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP
  • Sten Vermund, MD, PhD
  • Stefan Gravenstein, MD, MPH
  • Immunocompromised patients - Nov. 8th at 12pm ET
  • Lauren Angelo, PharmD, MBA
  • Ingi Lee, MD, MSCE
  • Mayur Ramesh, MD
  • Patients with chronic diseases - Nov. 14th at 12pm ET
  • Jeffery A. Goad, PharmD, MPH
  • Sumeska Thavarajah, MD
  • Onyema Ogbuagu, MB BCh, FACP, FIDSA
  • Patients with cardiovascular diseases - Nov. 16th at 2:30pm ET
  • Jeffery A. Goad, PharmD, MPH
  • Biykem Bozkurt, MD, PhD, FACC, FAHA, FHFSA, FACP
  • Orly Vardeny, PharmD, MS
  • Patients with respiratory diseases - Nov. 21st at 12pm ET
  • Wendy Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP
  • Albert Rizzo, MD, FACP, FCCP, FAASM
  • Juanita Mora, MD

Each event will focus on a different high-risk population. You're welcome to attend multiple events, but please register for each date separately.

Please note that in order to receive a webinar replay link, you must be registered for that event.


MED-US-NPSarsCOV2-2300485 10/2023

Moderna, Inc.

Our mission is to deliver the greatest possible impact to people through mRNA medicines.